12 Panel Drug Test Cup with BUP, TCA - Identify Health CLIA Waived

Identify Health 12 Panel Drug Test Cup - Configuration with TCA

The current expiration date for this drug test cup is on or better than: SEPTEMBER 24, 2025

Availability:
Ships same day if by 3pm EST. Signature required delivery.

- CLIA Waived
- FDA Cleared 510(K) 
- Urine temperature strip included
- We have two different configurations of our ID Health 12 Panel Cup. This version features TCA. The other configuration features PCP in place of TCA
- Purchase in bulk or small quantities to meet your specific volume needs
- Choose from cup pack sizes of: 25 cups
- Join our flexible auto-ship program to help make reordering easy
- Liquid Control Urine for this specific 12 panel drug test cup configuration is available HERE

Drugs Tested:
AMP - Amphetamines 500 ng/ml
BAR - Barbiturates 300 ng/ml
BUP - Buprenorphine 10 ng/ml
BZO - Benzodiazepines 300 ng/ml
COC - Cocaine 150 ng/ml
MDMA - Ecstasy 500 ng/ml
MET - Methamphetamines 500 ng/ml
MTD - Methadone 300 ng/ml
OPI300 - Morphine / Opiates 300 ng/ml
OXY - Oxycodone 100 ng/ml
TCA - Tricyclic Antidepressants 1,000 ng/ml
THC - Cannabinoid (Marijuana) 50 ng/ml

The Identify Health 12 panel drug test cup is a premium quality urine drug screening device used by medical professionals and also home office environments.

For the Identify Health drug test package CLIA insert please click the icon below:


The Identify Health 12 Panel Drug Test Cup is a CLIA Waived, point-of-care drug testing tool that is widely used in various settings, including healthcare facilities, workplaces, and schools. This drug test cup is designed to detect the metabolite presence of twelve different illicit narcotics or prescription medications in urine samples, providing fast and accurate results. The list of drugs screened are AMP - Amphetamines 500 ng/ml, BAR - Barbiturates 300 ng/ml, BUP - Buprenorphine 10 ng/ml, BZO - Benzodiazepines 300 ng/ml, COC - Cocaine 150 ng/ml, MDMA - Ecstasy 500 ng/ml, MET - Methamphetamines 500 ng/ml, MTD - Methadone 300 ng/ml, OPI300 - Morphine / Opiates 300 ng/ml, OXY - Oxycodone 100 ng/ml, TCA - Tricyclic Antidepressants 1,000 ng/ml, THC - Cannabinoid (Marijuana) 50 ng/ml.

One of the notable features of the Identify Health 12 Panel Drug Test Cup is its ability to detect tricyclic antidepressants, also known as TCA. TCA is a class of drugs commonly used to treat depression, anxiety, and other mental health disorders. It works by increasing the levels of certain neurotransmitters in the brain, including serotonin and norepinephrine, which help regulate mood, sleep, and other bodily functions. Please note: Our other Identify Health 12 panel cup tests for PCP instead of TCA. Look for SKU: ID-H12-1.

However, TCA can also cause several adverse effects, including dizziness, dry mouth, constipation, and blurred vision, among others. Moreover, it can interact with other medications and lead to serious health complications, particularly in elderly or vulnerable populations.

The decision to include TCA in the Identify Health 12 Panel Drug Test Cup reflects the importance of monitoring its use and potential misuse, particularly in healthcare settings. TCA is often prescribed by healthcare professionals, and patients may be less aware of its risks and potential side effects. Moreover, TCA use may be underreported or misdiagnosed, making it less of a concern for drug screening.

By including TCA in the Identify Health 12 Panel Drug Test Cup, healthcare providers and employers can ensure the safety and well-being of their patients and employees. By detecting TCA use, they can identify individuals who may be at risk of adverse effects or drug interactions, enabling early intervention and treatment. Moreover, they can prevent the misuse or diversion of TCA, reducing the risk of addiction and other health complications.

It is essential to note that the Identify Health 12 Panel Drug Test Cup should not be used as the sole means of identifying TCA use. Preliminary positive results with our Identify Health drug test cups should be confirmed in a laboratory setting as recommended by the US FDA.

In conclusion, the Identify Health 12 Panel Drug Test Cup is a powerful tool for drug screening, capable of detecting multiple substances, including tricyclic antidepressants. Its inclusion in the test cup reflects the importance of monitoring TCA use and potential misuse, particularly in healthcare settings. By detecting TCA use, healthcare providers and employers can ensure the safety and well-being of their patients and employees, enabling early intervention and treatment if necessary. Ultimately, drug testing, including TCA, is a critical step in identifying drug abuse and enabling early intervention and treatment, improving the health and well-being of individuals and communities alike.